Skip to main content
OpenTrials

Clinical trial condition

Neuroinflammatory Diseases

Explore clinical trials studying Neuroinflammatory Diseases. Study availability and eligibility vary by location and protocol.

1,038 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Neuroinflammatory Diseases trial results

Completed

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

NCT00657709

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • Grässl Hall in Tirol, Austria
  • Häckel Kirchdorf, Austria
  • Prieler Neufeld A.d. Leitha, Austria
  • Maurer Salzburg, Austria
View all 66 locations
View Trial Details
Completed

Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older

NCT01287949

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD investigational site Clermont-Ferrand, France
  • Sanofi Pasteur MSD investigational site Lille, France
  • Sanofi Pasteur MSD investigational site Montpellier, France
  • Sanofi Pasteur MSD investigational site Paris, France
View Trial Details
Completed

Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE

NCT01546909

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +18 more
Locations
  • SPMSD Investigational Site 120 Angers, France
  • SPMSD Investigational Site 103 Arras, France
  • SPMSD Investigational Site 155 Asnières, France
  • SPMSD Investigational Site 125 Bersée, France
View all 45 locations
View Trial Details
Completed

Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old

NCT01249183

Conditions
Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +24 more
Locations
  • Sanofi Pasteur MSD Investigational Site Angers, France
  • Sanofi Pasteur MSD Investigational Site Châtellerault, France
  • Sanofi Pasteur MSD Investigational Site Clermont-Ferrand, France
  • Sanofi Pasteur MSD Investigational Site Gières, France
View all 20 locations
View Trial Details
Completed

Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis

NCT00179478

Conditions
Acute Brainstem/Cerebellar Syndrome, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +25 more
Locations
  • MS Treatment Center at Griffin Hospital Derby, Connecticut, United States
  • Jaeb Center for Health Research Tampa, Florida, United States
  • MS Center of Atlanta Atlanta, Georgia, United States
  • Beta Research, Inc Elk Grove, Illinois, United States
View all 26 locations
View Trial Details

Related conditions